FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 348:2679-2681 June 26, 2003 Number 26 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Aaron, S. D. PubMed Citation

Chronic obstructive pulmonary disease (COPD) is a common disease that affects up to 24 million people in the United States and leads to substantial disability and death.¹ Patients with COPD have about three acute exacerbations of their disease per year,² many of which result in unscheduled visits to a physician or emergency department and to hospitalization. Although it is currently the fourth leading cause of death in the United States¹ and the sixth worldwide,³ COPD is predicted to be the third leading cause of death and fifth leading cause of disability in the world by 2020.³

Although there is no . . . [Full Text of this Article]

Source Information

From the Division of Pulmonary, Allergy, and Critical Care Medicine, University of Massachusetts Medical School, Worcester.

This article has been cited by other articles:

• Buhl, R., Farmer, S. G. (2004). Current and Future Pharmacologic Therapy of Exacerbations in Chronic Obstructive Pulmonary Disease and Asthma. Proc Am Thorac Soc 1: 136-142 [Abstract] [Full Text]